“As I Found It: My Mother’s House,” now available in bookstores, uses skillful photographs and heartfelt text to create a narrative that explores the ways in which dementia destroys history and meaning.

Thought Leader in Brain Health Joins Richard Stark and Company Co-Founders to Accelerate Innovation in Precision Medicine

Neurovations Research proud to be a part of study that released first positive results to slow Alzheimer's Disease

Project will use brain imaging and blood markers to detect the effects of Traumatic Brain Injury and distinguish them from Alzheimer's disease

Australian biotech Skin2Neuron Pty Ltd (S2N) has achieved what no one has to date - reversal of a dementia-like syndrome in a natural animal form of Alzheimer's disease.

CorInsights MRI Provides Exceptional Insight Using Brain Volume Quantitation

ElderHealth is a geriatric medical practice and virtual doctors office now accepting new patients in the Tucson, Marana, and Oro Valley areas.

Vivant Senior Living is pleased to announce that its first memory care home, Vivant at Versailles, completed a debt refinancing with Valley National Bank at a $1.1M valuation

Dr. Angelo Antonini, Dr. Matteo Bologna, Roy Jones, Dr. Fidias Leon-Sarmiento, and Dr. Fabrizio Stocchi, will help guide company as they advance central nervous system research

This year's event will feature renowned scientists and an opening meditation with special guest Deepak Chopra, M.D.

This marks the 11th U.S. provisional patent application filed by GBS covering the use of CCCM™ for unique medical disorders, creating an IP portfolio that contains formulas for up to 50 potential therapeutic indications.

Mr. Riley to Lead Corporate Development Efforts as Company Targets New Clinical Applications for its Proprietary, FDA-Cleared Blink Reflex Technology

With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.

New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.

NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer's disease.

St. Catherine's Village is a private, gated community boasting wooded grounds, protected and beautiful outdoor spaces, a caring staff, resident-centered memory care, and a mission-focused environment for adults age 62 and older.

Day of Awareness Set for September 14

St. Catherine's Village has just opened the Tuscany Skilled Nursing Center. This new expansion offers 54 private skilled nursing rooms.

New Trilogy Senior Living Community to Offer Memory Care Services

New Trilogy Senior Living Community to Offer Memory Care Services

Campus Celebrates Addition of Memory Care Neighborhood

Study by Gladstone scientists finds blood protein destroys memory storage sites in the brain and may lead to new treatments

New residents who move into Campbell Cove by March 1, 2019, with a rental contract for memory care assisted living can save 10 percent on monthly service fees for one year.

Senior Living Provider Invests in a Brighter Future for Local Seniors and Students

Gladstone scientists uncover new gatekeeper function of the anti-aging molecule

A recent review suggests that a phospholipid form of omega-3 in fish and fish roe may reduce Alzheimer's disease risk in APOE4 carriers.

DISCERN™ is the most accurate, least invasive and most cost-effective test for identifying Alzheimer's Disease

Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks

Scientists shed light on cells' most fundamental process

BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders

The public is invited to attend a FREE educational seminar, Understanding Dementia, Alzheimer's Disease And Parkinson's Disease, on Saturday, July 21 at St. Catherine's Village in Madison, Mississippi.

New insights into how a gene causes damage could impact future drug development

Transplanting a special type of neuron into the brain restores cognitive functions in Alzheimer's models, shows a new study by Gladstone scientists

Dr. Thomas Mosley will share the latest advances in Alzheimer's and dementia research occurring at UMMC's MIND Center during a free seminar at St. Catherine's Village in Madison, Mississippi on March 29 at 2:30 p.m.

Immunoprecipitation in combination with mass spectrometry is a powerful tool for studying disease-associated proteins

Madison the City Chamber of Commerce—which is comprised of businesses, professionals and volunteers whose mission is to advance the city's economic vitality and quality of life—presented the 2017 Large Business of the Year Award to St. Catherine's Village.

World's first "Citizen Science" award will be presented to students by the Human Computation Institute at a middle school assembly tomorrow

The Neurologist's Healthy Brain Toolbox from Dr. Ken Sharlin

Study from the Gladstone Institutes may lead to new treatments for diseases like multiple sclerosis

Scientists develop a cheaper, quicker, and more reliable stem cell-based technology to facilitate drug discovery

For a limited time only — St. Catherine's Village is offering fall specials on several of its living options including memory care, skilled nursing, and independent studio apartments.

A new center at Gladstone aims to find unforeseen uses for existing drugs

E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders

Partners with the Dana Foundation to distribute Roberto app and increase consumer focus on the importance of ongoing brain health monitoring

Four Neurology Experts Join Advisory Board Following Recent Breakthrough Discoveries Regarding Posiphen Mechanism of Action

Human Computation Institute launches a new citizen science game as part of the EyesOnALZ citizen science project.

Brain Tune Up! is a program designed to help those with neurological conditions take back their health.

NeuroQuest's blood-based biomarker test for early diagnosis of Alzheimer's disease exceeded U.S. Alzheimer's Association standards during recent pilot study in Australia. NeuroQuest has contracted with a major U.S. university to oversee collection and processing of 700 samples for their national clinical trial. The NeuroQuest blood test can potentially identify a pre-clinical stage of AD in a person years before the onset of noticeable symptoms, paving the way for new therapies and research.

Zeena Nackerdien, a scientist turned novelist, synthesized relationships, headlines, mythology, history, science, religion, and sports, through her mental prism in two books: Mist over Peace (genre: poetry) and The Heroine Next Door (genre: fiction).

Zeena Nackerdien, a scientist turned novelist, synthesized relationships, headlines, mythology, history, science, religion, and sports, through her mental
prism as a South-African-born US citizen in an innovative poetry book, Mist over Peace.